Offner Technologies | Radiation-Free Acoustic Medical Imaging
NL-SWI · Natural Locking Standing Wave

Offner Technologies

The next generation of a precision measurement platform.

Empowering Clinicians. Redefining Patient Solutions.

Unprecedented precision. A standing micro-vibration that reaches any depth in the body — while nothing enters it. Sub-micron detail of every organ. No harmful radiation.

  • Surgical Precision Without the Incision Bladeless navigation through dense structures — map pathways, reach through the skull, visualize hidden cavities — designed to cut diagnostic ambiguity, not tissue.
  • Clinical Mastery Through Unmatched Metrics Real-time tissue composition and drug-effect readings — designed to replace delayed lab results and secondary symptoms with immediate certainty.
  • Dynamic Throughput and Optimized Workflows Static and dynamic deep-tissue imagery captured in minutes, inside a standard consultation — no diagnostic bottlenecks.
  • High-Yield Practice Differentiation Cutting-edge diagnostic pathways patients cannot find elsewhere — a natural magnet for premium demand and a new revenue stream.
Why partner See the principle
35+
Years founder track record
~1,000
Units of the founder's prior platform sold (different medical application)
26
Patents held, many medical
11
Medical applications, one core
0
Ionizing radiation by design
Concept visualization
The compromise we're ending

Breaking the compromise: medicine unleashed from physics.

For a century, diagnostics forced physicians and patients into a painful trade: to see clearly, you had to hurt, expose, or wait. High frequencies delivered crisp detail but died at bone, leaving diagnostic blind spots; low frequencies reached deep but blurred, forcing clinicians to guess. The industry adapted by building around the limit — multi-million-dollar chambers, radiation, needles. We think the fixed boundary was never physics; it was the way we measured. Switch from measuring wave size to tracking a wavefront's exact picosecond arrival — and the compromise disappears.

The skull is no longer a wall

The patient's life

When a stroke hits, every second helps decide whether a patient walks, speaks, or recovers. Today, a clear look inside the brain means a claustrophobic journey into a multi-million-dollar MRI chamber — or a weeks-long wait.

The clinician's gain

NL-SWI is designed to turn a facility crisis into a bedside reality: safely passing dense adult bone without surrendering resolution, so neurological monitoring becomes a continuous, safe baseline instead of a scheduled event.

Zero radiation, zero cumulative fear

The patient's life

Every conventional scan is a silent trade: information for exposure. For chronic patients and children, that exposure accumulates — a physical and psychological toll that lasts a lifetime.

The clinician's gain

A phase-locked resonance loop whispers sound instead of shouting raw energy — radiation-free by design. Monitoring can run continuously, hour after hour, with no exposure ceiling and none of the scan anxiety that keeps patients away.

Freedom from the needle

The patient's life

For millions living with diabetes or complex metabolic conditions, tracking health means a life dictated by lancing and pain. The metrics they need most are trapped behind blood and skin.

The clinician's gain

By translating molecular thermal expansion into instant acoustic time signatures, the system is designed to measure glucose and track pharmaceutical efficacy non-invasively — real-time metabolic data in a routine, pain-free consultation.

Precision unbound by the blade

The patient's life

Internal exploration carries a visceral dread: diagnostic ambiguity too often ends in exploratory incisions, needles, or catheters — just to locate a target.

The clinician's gain

A picosecond electronic clock is designed to reach sub-micron resolution past the wavelength limit — "bladeless" peering into hidden cavities and organs-within-organs, replacing blind intervention with visual certainty.

The uncompromised proof

The physics has more room than the industry uses.

The absolute limits medical imaging has accepted for a century are not laws of physics — they are artifacts of how the industry chose to measure. Conventional acoustic sensing bound spatial accuracy to the size of the wave itself. We unbuilt that assumption: a standing wave established between two simple transducers — no heavy lenses, no expensive phased arrays — locks onto the target's own resonance and counts thousands of uninterrupted cycles. Frequency then dictates reach alone; accuracy comes exclusively from elapsed time. The longer the clock listens, the deeper and sharper the data. These are consequences of the physics. We intend to prove them early, in public.

Proof 01 · NASA Langley

0.00038 radians — the ceiling is higher than assumed

The independent proof

An independent study at the NASA Langley Research Center showed how far ultrasonic phase measurement can reach. In rigorous materials testing, researchers achieved a phase resolution corresponding to a thickness error of just 0.04 µm — about forty nanometers — in dense solids. The test did not involve NL-SWI, and it was not run in tissue.

The human outcome

If a low-frequency wave can resolve forty nanometers of thickness in dense solids, the ceiling for medical sensing is far higher than the field assumes. For the clinician, that points to sub-micron diagnostic precision. For the patient — a clear, non-invasive look through dense barriers like the adult skull: a design goal we are building toward.

Proof 02 · A law since 1954

Sugar bends the speed of sound — documented in 1954

The independent proof

As early as 1954, science documented that the speed of sound in a fluid shifts deterministically with the concentration of dissolved sugar. The biochemical data has been sitting inside ordinary sound — unmeasured — for over seventy years.

The human outcome

Traditional echo-amplitude tracking was too blunt to capture it non-invasively. By reading the ultra-precise phase shift over time instead of a blurred echo size, NL-SWI is designed to turn that 1954 physical law into a bedside capability — tracking glucose and pharmaceutical metabolism through the skin, painlessly and without a single needle.

Frequency chooses reach. Accuracy comes from time. That single move decouples two things the field has always fused.
Read the full technology breakdown →
One core engine · Four of many

One core engine. Multiple life-changing applications.

One measurement core, eleven mapped medical applications — and the set does not end there. The four below are worked examples: any bounded space the wave can reach, with no hardware change, is a candidate application.

Application 01

Needle-free glucose tracking — through the eyelid

The patient's life

No more daily finger-pricks, lancets, test strips, or chronic skin trauma — the metabolic baseline is designed to be read painlessly, through intact skin.

The clinician's gain

Directing a resonant acoustic wave non-invasively through the thin tissue of the eyelid, the system is designed to capture the fluid's phase-velocity shifts instantly [Pryor & Roscoe, 1954] — real-time, zero-contact glucose metrics during a standard consultation.

Application 02

The virtual catheter — deep-vessel metrics without intrusion

The patient's life

Physical tubes, guide wires, and invasive pressure sensors pushed into veins, chambers, or bladder carry real discomfort, vascular-injury risk, and infection danger. The design goal: deep-vessel metrics with nothing entering the body.

The clinician's gain

Navigation maps today are blind — physical insertion followed by secondary X-ray confirmation, with misplacement rates that remain a documented clinical burden. Sub-micron clock precision is designed to act as a virtual catheter: locking onto internal boundary coordinates from outside the body to measure fluid dynamics, trace vessel flows, and audit inner spaces in real time — no insertion trauma.

Application 03

Multi-layer arterial plaque audits

The patient's life

Cardiovascular risk assessment stops being a guessing game based on blood pressure alone — an early, clear warning of arterial change before an event occurs, without invasive angiograms.

The clinician's gain

The system is designed to lock onto the acoustic boundaries of vascular tissue and audit arterial walls in high resolution, layer by layer — measuring plaque thickness and stability with structural clarity.

Application 04

Unmasking early-stage anomalies & real-time tissue tracking

The patient's life

Liberation from the anxious "six-month waiting window" to see whether a blurry shadow grows. With zero ionizing radiation or harmful energy by design, follow-up is intended to be safe to repeat — monitoring tissue response and healing week after week, without cumulative-exposure fear.

The clinician's gain

Traditional echo and CT force a choice between diagnostic insight and cumulative exposure. A phase-locked resonance loop accumulates data through harmless ultrasonic whispers — designed for continuous, dynamic therapeutic tracking: evaluate treatment efficacy, observe cellular-scale shifts, and adjust protocols on live, immediate feedback.

Four worked examples — not a catalog. One core, no hardware changes: any bounded space the wave can reach is an application.

Applications

See inside. Without harm.

The commercial deployment is narrow on purpose: every image is a design goal derived from clock data — not from acoustic compromise, and not a measured result. The patent-pending, phase-locked wavefront architecture is designed to set a new bar for patient safety and physician mastery across eleven clinical targets, led by an initial launch portfolio:

01 · Brain

Bedside stroke assessment

Designed to bypass the intact adult skull when minutes dictate survival.

02 · Glucose

Needle-free metabolic tracking

Real-time glucose and live drug-efficacy readouts, designed to be captured painlessly through the eyelid.

03 · Heart

The virtual catheter

Auditing deep cardiac cavities and internal fluid tracks entirely from outside the body.

04 · Arteries

Multi-layer plaque audits

Mapping vascular thickness layer by layer — and tracking early-stage change with zero ionizing radiation.

05 · Oncology & Healing

Real-time cellular-scale tracking

Designed to follow microscopic tissue change and treatment response over time — with no cumulative-exposure ceiling.

06 · Fetus

Zero-contact obstetric imaging

No transducer pressure on the scan line — a contact-free design approach to prenatal evaluation.

07 · Lungs

Deep-tissue thoracic audits

Designed to cross the air and gas barriers that completely block traditional ultrasound.

08 · Skin

Advanced wound evaluation

Underlying tissue regeneration and micro-circulation — zero contact, zero pain, nothing cut.

All eleven applications →
The multi-layer architecture

Empirical precision meets intelligent interpretation.

The system separates raw-data extraction from its clinical analysis. The hardware layer is designed to produce the measurement itself — uncompromised, physics-first — while an integrated, secure software layer structures, flags, and contextualizes it for the clinician in real time. Because the hardware footprint is remarkably streamlined, that intelligence is designed to travel: from a metropolitan hospital to a remote bedside consultation.

A node measures. The clinician decides. We intend to deliver both.
Layer 01 · The acoustic core

Measurement

Two simple transducers — no heavy lenses, no phased arrays. The node is designed to lock onto biological resonance and extract raw picosecond wavefront clock data from deep within tissue.

Layer 02 · The cognitive expert

Interpretation

An integrated software intelligence, designed to serve as a real-time clinical decision support system — classifying structures, flagging anomalies, and mapping metabolic change directly into the physician's workflow.

Layer 03 · Universal mobility

Distribution

Uncoupling diagnostic precision from heavy enclosures: streamlined, low-cost sensor nodes plus cloud-secure intelligence — designed to go wherever the doctor goes, not just specialized imaging rooms.

NL-SWI scanner — concept visualization
Founder video — why now
2:00
Leadership & heritage

A legacy of proven measurement architecture.

This technology is not an unverified scientific hypothesis — it is the direct evolution of a mature, field-tested engineering paradigm. Founder Arie Ariav has spent over 35 years pioneering advanced sensor architectures and precision measurement instrumentation. The initial generation of this sensing platform was developed, manufactured, and deployed in ~1,000 units to market-leading global enterprises — alongside a portfolio of 26 foundational global patents, with a substantial core dedicated to deep medical imaging, non-invasive diagnostic sensors, and neuro-acoustics.

His baseline tracking methodologies passed rigorous technology due diligence at four global industry leaders; his 2005 patent for sensor-based cardiac gating (U.S. 2006/0264739) was later cited in General Electric's own patent, and GE applied his earlier technology in its MRI systems — presented at the RSNA annual meeting. With Offner Technologies, Ariav leverages this field-proven IP heritage for the next generation of non-invasive diagnostics — the baseline physics has already faced the industry's toughest scrutiny.

Read the full story →
The partnership model

We engineered the baseline physics. We're looking for the strategic partner to build the devices.

Offner Technologies operates strictly as an intellectual-property and core-technology invention company — not a manufacturer. Our core competencies are advanced acoustic physics, signal-processing architecture, and foundational IP, including our newly filed March 2026 U.S. patent application. We are seeking an established industry partner or institutional collaborator to co-develop the framework into a functional clinical prototype, and from there to a manufacturable, regulatory-cleared medical device.

Strategic capabilities sought
  • Product development & engineering — from early functional prototype to a scalable, manufacturing-ready commercial design
  • Medical-device manufacturing — scalable production under ISO 13485 and cleanroom standards
  • Regulatory & clinical validation — experience navigating international tracks to FDA and CE clearance
  • Global healthcare distribution — B2B networks into tier-one hospital systems
Active intellectual-property track

Patent pending: Natural Locking Standing Wave Imaging (NL-SWI) — U.S. Provisional Application No. 63/996,286, filed March 2026. Author: Arie Ariav.

Investor & partner FAQ

Questions strategic partners ask first.

What is NL-SWI?

The absolute brief — Natural Locking Standing Wave Imaging (NL-SWI) is our proprietary, patent-pending acoustic measurement methodology. Instead of forcing an external frequency onto biological tissue and measuring a blurred echo amplitude, the architecture establishes a closed phase-locked loop between transducers. This loop locks onto the natural structural resonance of the target biological boundary. As a result, spatial precision is shifted away from acoustic-wavelength limitations and is governed entirely by digital, ultra-precise picosecond timing electronics.

How does NL-SWI differ from conventional ultrasound?

The absolute brief — Conventional diagnostic ultrasound is bound to an immutable physics compromise: it trades depth for detail. Low frequencies penetrate deeply but yield coarse, ambiguous imagery, while high frequencies provide crisp resolution but fail at dense barriers. NL-SWI is designed to uncouple these two parameters completely. The operating frequency is selected exclusively for depth of penetration, while sub-micron, resolution-scale accuracy is maintained at any depth — including non-invasive transcranial imaging directly through the intact adult skull.

What is the current development stage of Offner Technologies?

The absolute brief — Our core foundational IP track was officially advanced with the filing of our provisional patent application with the USPTO in March 2026. The baseline physics of phase-locked wavefront measurement stands grounded in independent, peer-reviewed research conducted at NASA Langley — an independent study that did not test NL-SWI itself. With our multi-vertical product roadmap firmly established, we are prepared for the immediate next milestone: co-developing the first fully functional, regulatory-compliant clinical prototype alongside a strategic partner.

What specific profile is Offner Technologies seeking in a strategic partner?

The absolute brief — We are looking for premier product development and biomedical engineering teams equipped to transition our core physics into a commercial-grade, scalable design. Following initial prototype optimization, our roadmap integrates long-term strategic alliances with partners specializing in ISO 13485-compliant medical manufacturing, international clinical validation (FDA and CE tracks), and established global distribution networks into tier-one healthcare systems.

For technology hunters

Is the technology available for licensing or investment?

The absolute brief — Offner Technologies is selecting one exclusive strategic partner per domain for co-development, licensing, and commercialization. The platform is patent-pending (U.S. Application No. 63/996,286, filed March 2026). Previous generations of the core technology were validated through partnerships with GE, Johnson & Johnson, and Samsung.

What physics backs this technology?

The absolute brief — The measurement principle — sub-micrometer precision via phase-locked ultrasonic measurement — was independently demonstrated at NASA Langley Research Center (Haldren et al., Review of Scientific Instruments 89, 054902, 2018). That study did not test NL-SWI itself; it shows the validated precision ceiling is far above what conventional acoustic sensing assumes.

Is there an MRI alternative without radiation or helium?

The absolute brief — The NL-SWI platform is designed to deliver MRI-level soft-tissue and CT-level structural imaging in one portable device — with no ionizing radiation, no contrast agents, and no helium dependency. This is the design goal - the first device is the next milestone.

For patients and families

Can blood sugar be measured without pricking a finger?

The absolute brief — Today, every glucose reading — lancet or CGM sensor — breaks the skin. NL-SWI is designed to read the tissue changes that glucose causes, through intact skin, starting as a trending device used alongside your current monitor. This is the design goal and not yet a product; clinical validation is pending. Always follow your physician's guidance.

Is there an alternative to coronary catheterization?

The absolute brief — Virtual catheterization is our design goal: a 3D map of the coronary arteries — including soft and calcified plaque — built from measurements taken outside the body, with no catheter insertion, no contrast dye, and no radiation. It is not clinically available yet.

Can a stroke be detected before the damage spreads?

The absolute brief — NL-SWI is designed to image through the intact skull with no radiation, so stroke detection could in principle begin before the hospital — in the ambulance or at home, with continuous monitoring. This capability is a design goal - the first device is the next milestone. If you suspect a stroke, call emergency services immediately.